Exhaled molecular profiles in the assessment of cystic fibrosis and primary ciliary dyskinesia

Journal of Cystic Fibrosis

Volumn 12, Issue 5, 2013, Pages 454-460

  Paff, T ^a   van der Schee, M P ^a,b   Daniels, J M A ^a   Pals, G ^a   Postmus, P E ^a   Sterk, P J ^b   Haarman, E G ^a,b  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Cystic fibrosis; Electronic nose; Exhaled breath; Primary ciliary dyskinesia; Volatile Organic Compounds

Indexed keywords

ACHROMOBACTER DENITRIFICANS; ADOLESCENT; ARTICLE; BREATH ANALYSIS; CASE CONTROL STUDY; CHILD; CILIARY DYSKINESIA; CLINICAL ARTICLE; CONTROLLED STUDY; COUGHING; CROSS-SECTIONAL STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE EXACERBATION; ELECTRONIC NOSE; EXPIRED AIR; FEMALE; HAEMOPHILUS INFLUENZAE; HUMAN; LUNG FIBROSIS; MALE; MORAXELLA CATARRHALIS; MYCOBACTERIUM AVIUM; PATIENT MONITORING; SCHOOL CHILD; SENSITIVITY AND SPECIFICITY; SPUTUM ANALYSIS; SPUTUM CULTURE; STAPHYLOCOCCUS AUREUS; STENOTROPHOMONAS MALTOPHILIA; STREPTOCOCCUS PNEUMONIAE;

CYSTIC FIBROSIS; ELECTRONIC NOSE; EXHALED BREATH; PRIMARY CILIARY DYSKINESIA; VOLATILE ORGANIC COMPOUNDS;

ADOLESCENT; BREATH TESTS; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; CYSTIC FIBROSIS; FEMALE; HUMANS; INFANT; KARTAGENER SYNDROME; MALE;

EID: 84882913590     PISSN: 15691993     EISSN: 18735010     Source Type: Journal    
DOI: 10.1016/j.jcf.2012.12.010     Document Type: Article

References (30)

1. Barbato A., Frischer T., Kuehni C.E., Snijders D., Azevedo I., Baktai G., et al. Primary ciliary dyskinesia: a consensus statement on diagnostic and treatment approaches in children. Eur Respir J Dec. 2009, 34(6):1264-1276.
2. Ellerman A., Bisgaard H. Longitudinal study of lung function in a cohort of primary ciliary dyskinesia. Eur Respir J Oct. 1 1997, 10(10):2376-2379.
3. Strippoli M., Frischer T., Barbato A., Snijders D., Maurer E., Lucas J.S.A., et al. Management of primary ciliary dyskinesia in European children: recommendations and clinical practice. Eur Respir J 2012, 39(6):1482-1491.
4. Flume P.A., Mogayzel P.J., Robinson K.A., Goss C.H., Rosenblatt R.L., Kuhn R.J., et al. Pulmonary perspective cystic fibrosis pulmonary guidelines: treatment of pulmonary exacerbations. Am J Respir Crit Care Med 2009, 180:802-808.
5. Gibson R.L., Burns J.L., Ramsey B.W. Pathophysiology and management of pulmonary infections in cystic fibrosis. Am J Respir Crit Care Med Oct. 15 2003, 168(8):918-951.
6. Zhu J., Bean H.D., Kuo Y.M., Hill J.E. Fast detection of volatile organic compounds from bacterial cultures by secondary electrospray ionization-mass spectrometry. J Clin Microbiol 2010, 48(12):4426-4431.
7. Buszewski B., Kesy M., Ligor T., Amann A. Human exhaled air analytics: biomarkers of diseases. Biomed Chromatogr 2007, 566:553-566.
8. Fens N., Nijs S.B.D., Peters S., Dekker T., Knobel H.H., Vink T.J., et al. Exhaled air molecular profiling in relation to inflammatory subtype and activity in COPD. Eur Respir J 2011, 38(6):1301-1309.
9. Ibrahim B., Basanta M., Cadden P., Singh D., Douce D., Woodcock A., et al. Non-invasive phenotyping using exhaled volatile organic compounds in asthma. Thorax 2011, 66(9):804-809.
10. Robroeks C.M.H.H.T., van Berkel J.J.B.N., Dallinga J.W., Jöbsis Q., Zimmermann L.J.I., Hendriks H.J.E., et al. Metabolomics of volatile organic compounds in cystic fibrosis patients and controls. Pediatr Res Jul. 2010, 68(1):75-80.
11. Walker W.T., Jackson C.L., Lackie P.M., Hogg C., Lucas J.S. Nitric oxide in primary ciliary dyskinesia. Eur Respir J Oct. 2012, 40(4):1024-1032.
12. Röck F., Barsan N., Weimar U. Electronic nose: current status and future trends. Chem Rev 2008, 108(2):705-725.
13. Wilson A.D., Baietto M. Advances in electronic-nose technologies developed for biomedical applications. Sensors Jan. 2011, 11(1):1105-1176.
14. Fens N., Zwinderman A.H., van der Schee M.P. Exhaled breath profiling enables discrimination of chronic obstructive pulmonary disease and asthma. Am J Respir Crit Care Med Dec. 1 2009, 180(11):1076-1082.
15. Fens N., Roldaan A.C., van der Schee M.P., Boksem R.J., Zwinderman A.H., Bel E.H., et al. External validation of exhaled breath profiling using an electronic nose in the discrimination of asthma with fixed airways obstruction and chronic obstructive pulmonary disease. Clin Exp Allergy Jul. 7 2011, 41(10):1371-1378.
16. Dragonieri S., Annema J.T., Schot R., van der Schee M.P., Spanevello A., Carratú P., et al. Lung cancer an electronic nose in the discrimination of patients with non-small cell lung cancer and COPD. Lung Cancer 2009, 64:166-170.
17. Westhoff M., Litterst P., Freitag L., Urfer W., Bader S., Baumbach J.-I. Ion mobility spectrometry for the detection of volatile organic compounds in exhaled breath of patients with lung cancer: results of a pilot study. Thorax Sep. 2009, 64(9):744-748.
18. Hanson C., Thaler E.R. Electronic nose prediction of a clinical pneumonia score: biosensors and microbes. Anesthesiology 2005, 1:63-68.
19. Bossuyt P.M., Reitsma J.B., Bruns D.E., Gatsonis C.A., Glasziou P.P., Irwig L.M., et al. The STARD statement for reporting studies of diagnostic accuracy: explanation and elaboration. Ann Intern Med 2003, 138(1):1-12.
20. Miller M.R., Hankinson J., Brusasco V., Burgos F., Casaburi R., Coates A., et al. Standardisation of spirometry. Eur Respir J 2005, 26(2):319-338.
21. Farrell P.M., Rosenstein B.J., White T.B., Accurso F.J., Castellini C., Cutting G.R., et al. Guidelines for diagnosis of cystic fibrosis in newborns through older adults: cystic fibrosis foundation consensus report. J Pediatr 2008, 153(2):S4-S14.
22. Hirst R.a., Rutman A., Williams G., O'Callaghan C. Ciliated air-liquid cultures as an aid to diagnostic testing of primary ciliary dyskinesia. Chest Dec. 2010, 138(6):1441-1447.
23. Kwaliteitsinstituut voor de Gezondheidszorg CBO Richtlijn Diagnostiek en Behandeling Cystic Fibrosis 2009.
24. Bilton D., Canny G., Conway S., Dumcius S., Hjelte L., Proesmans M., et al. Pulmonary exacerbation: towards a definition for use in clinical trials. Report from the EuroCareCF Working Group on outcome parameters in clinical trials. J Cyst Fibros Jun. 2011, 10(Suppl. 2):S79-S81.
25. Broadhurst D.I., Kell D.B. Statistical strategies for avoiding false discoveries in metabolomics and related experiments. Metabolomics Nov. 28 2006, 2(4):171-196.
26. Sibley C.D., Grinwis M.E., Field T.R., Eshaghurshan C.S., Faria M.M., Dowd S.E., et al. Culture enriched molecular profiling of the cystic fibrosis airway microbiome. PLoS One Jan. 2011, 6(7):e22702.
27. Zariwala M.a., Knowles M.R., Omran H. Genetic defects in ciliary structure and function. Annu Rev Physiol Jan. 2007, 69:423-450.
28. Bush A., Payne D., Pike S., Jenkins G., Henke M.O., Rubin B.K. Mucus properties in children with primary ciliary dyskinesia: comparison with cystic fibrosis. Chest Jan. 2006, 129(1):118-123.
29. Mackerness K.J., Jose P.J., Bush A. Differences in airway inflammation in cystic fibrosis and primary ciliary dyskinesia. Pediatr Asthma Allergy Immunol 2009, 22(4):163-168.
30. Kuehni C.E., Frischer T., Strippoli M.-P.F., Maurer E., Bush A., Nielsen K.G., et al. Factors influencing age at diagnosis of primary ciliary dyskinesia in European children. Eur Respir J Dec. 2010, 36(6):1248-1258.